Broderick Brian C boosted its holdings in Danaher Corporation (NYSE:DHR) by 8.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 61,810 shares of the conglomerate’s stock after buying an additional 4,995 shares during the period. Danaher Corporation accounts for approximately 1.9% of Broderick Brian C’s holdings, making the stock its 22nd largest holding. Broderick Brian C’s holdings in Danaher Corporation were worth $5,301,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of DHR. BlackRock Inc. lifted its stake in shares of Danaher Corporation by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after purchasing an additional 36,524,795 shares in the last quarter. Flossbach Von Storch AG lifted its stake in shares of Danaher Corporation by 44.7% in the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after purchasing an additional 1,785,810 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Danaher Corporation by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after purchasing an additional 1,530,015 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Danaher Corporation by 16,410.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares in the last quarter. Finally, Koch Industries Inc. lifted its stake in shares of Danaher Corporation by 29,127.3% in the 2nd quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock valued at $1,388,000 after purchasing an additional 1,399,859 shares in the last quarter. 75.38% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Danaher Corporation (NYSE:DHR) opened at $93.33 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. Danaher Corporation has a twelve month low of $76.27 and a twelve month high of $93.38. The stock has a market capitalization of $64,162.62, a P/E ratio of 23.71, a price-to-earnings-growth ratio of 2.19 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same period in the previous year, the business earned $0.87 EPS. Danaher Corporation’s revenue for the quarter was up 9.6% compared to the same quarter last year. equities analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.60%. Danaher Corporation’s dividend payout ratio is presently 16.52%.
In other news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of Danaher Corporation stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the transaction, the chief executive officer now owns 271,737 shares in the company, valued at approximately $25,173,715.68. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the transaction, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. Insiders have sold a total of 279,628 shares of company stock worth $25,304,394 over the last 90 days. 12.20% of the stock is owned by company insiders.
Several equities analysts have recently weighed in on DHR shares. Morgan Stanley lifted their price objective on Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research note on Friday, October 20th. Credit Suisse Group lifted their price objective on Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Zacks Investment Research raised Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and issued a $83.00 price objective on shares of Danaher Corporation in a research note on Tuesday, September 26th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $93.31.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.